Rare diseases
Investigational molecules
Locations
Back to France3 344 clinical trials in Le Chesnay-Rocquencourt, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Long‑Term Safety and Tolerability of Frexalimab Drug Combination in Adults with Multiple Sclerosis
FranceStudy of Daily Oral Ibutamoren Mesilate in Treatment‑Naïve Prepubertal Children with Growth Hormone Deficiency
FranceImmunogenicity and safety of intradermal zoonotic influenza vaccine (H5N8) compared with intramuscular administration in adults 40–80 years with avian influenza
FrancePhase 1/2 study of AVZO-023 drug combination in patients with advanced cancer
FrancePhase 2 Study of Oral VS-7375 in Adults with Advanced KRAS G12D‑Mutated Non‑Small Cell Lung Cancer Previously Treated
FrancePhase 1b study of empasiprubart in adults with multifocal motor neuropathy to assess nerve morphology by ultrasound
FranceStudy of Baricitinib and Sirolimus to Maintain HIV Infection Control After Antiretroviral Treatment Interruption in Adults
FranceGedatolisib with drug combination versus standard therapy as first‑line treatment for patients with advanced HR‑positive HER2‑negative breast cancer
FranceLong‑term safety of intrathecal VO659 in participants with Huntington’s disease, spinocerebellar ataxia type 1 or type 3
FranceStudy of saruparib plus AR inhibitor drug combination in men with metastatic hormone‑sensitive prostate cancer previously treated with docetaxel or Lu‑PSMA and PSA ≥0.2 ng/mL
FranceLow-dose isotretinoin compared with drug combination for treating acne in adult women: a two‑step randomized trial
FranceStudy of quizartinib‑based drug combination on measurable residual disease in adults 18‑60 with acute myeloid leukemia
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on acute myocardial infarction pain management and innovative treatments for severe asthma. Research includes evaluation of novel pain-relief methods and assessment of treatment discontinuation strategies.
Studies also examine beta-blocker discontinuation in patients with recovered heart function.
Extensive research in blood cancers, including multiple myeloma, acute myeloid leukemia, and various lymphomas. Studies evaluate novel drug combinations and treatment strategies.
Investigations include targeted therapies and personalized treatment approaches for various cancer types.
Research focusing on respiratory syncytial virus (RSV) prevention in infants and children. Studies evaluate new protective treatments and their safety profiles.
Trials include assessment of novel medications for preventing severe respiratory infections in vulnerable populations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
